155 related articles for article (PubMed ID: 14662322)
1. SHIP, SHIP2, and PTEN activities are regulated in vivo by modulation of their protein levels: SHIP is up-regulated in macrophages and mast cells by lipopolysaccharide.
Sly LM; Rauh MJ; Kalesnikoff J; Büchse T; Krystal G
Exp Hematol; 2003 Dec; 31(12):1170-81. PubMed ID: 14662322
[TBL] [Abstract][Full Text] [Related]
2. The role of SHIP in cytokine-induced signaling.
Kalesnikoff J; Sly LM; Hughes MR; Büchse T; Rauh MJ; Cao LP; Lam V; Mui A; Huber M; Krystal G
Rev Physiol Biochem Pharmacol; 2003; 149():87-103. PubMed ID: 12692707
[TBL] [Abstract][Full Text] [Related]
3. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells.
Choi Y; Zhang J; Murga C; Yu H; Koller E; Monia BP; Gutkind JS; Li W
Oncogene; 2002 Aug; 21(34):5289-300. PubMed ID: 12149650
[TBL] [Abstract][Full Text] [Related]
4. Role of Src homology 2-containing-inositol 5'-phosphatase (SHIP) in mast cells and macrophages.
Rauh MJ; Kalesnikoff J; Hughes M; Sly L; Lam V; Krystal G
Biochem Soc Trans; 2003 Feb; 31(Pt 1):286-91. PubMed ID: 12546703
[TBL] [Abstract][Full Text] [Related]
5. Evidence that SHIP-1 contributes to phosphatidylinositol 3,4,5-trisphosphate metabolism in T lymphocytes and can regulate novel phosphoinositide 3-kinase effectors.
Freeburn RW; Wright KL; Burgess SJ; Astoul E; Cantrell DA; Ward SG
J Immunol; 2002 Nov; 169(10):5441-50. PubMed ID: 12421919
[TBL] [Abstract][Full Text] [Related]
6. Tyrosine phosphorylation of SHIP promotes its proteasomal degradation.
Ruschmann J; Ho V; Antignano F; Kuroda E; Lam V; Ibaraki M; Snyder K; Kim C; Flavell RA; Kawakami T; Sly L; Turhan AG; Krystal G
Exp Hematol; 2010 May; 38(5):392-402, 402.e1. PubMed ID: 20304029
[TBL] [Abstract][Full Text] [Related]
7. Role of SHIP in cancer.
Hamilton MJ; Ho VW; Kuroda E; Ruschmann J; Antignano F; Lam V; Krystal G
Exp Hematol; 2011 Jan; 39(1):2-13. PubMed ID: 21056081
[TBL] [Abstract][Full Text] [Related]
8. SHIP2 multiple functions: a balance between a negative control of PtdIns(3,4,5)P₃ level, a positive control of PtdIns(3,4)P₂ production, and intrinsic docking properties.
Erneux C; Edimo WE; Deneubourg L; Pirson I
J Cell Biochem; 2011 Sep; 112(9):2203-9. PubMed ID: 21503961
[TBL] [Abstract][Full Text] [Related]
9. Differential association of phosphatidylinositol 3-kinase, SHIP-1, and PTEN with forming phagosomes.
Kamen LA; Levinsohn J; Swanson JA
Mol Biol Cell; 2007 Jul; 18(7):2463-72. PubMed ID: 17442886
[TBL] [Abstract][Full Text] [Related]
10. The role of SHIP in growth factor induced signalling.
Huber M; Helgason CD; Damen JE; Scheid M; Duronio V; Liu L; Ware MD; Humphries RK; Krystal G
Prog Biophys Mol Biol; 1999; 71(3-4):423-34. PubMed ID: 10354708
[TBL] [Abstract][Full Text] [Related]
11. SHIPs ahoy.
Krystal G; Damen JE; Helgason CD; Huber M; Hughes MR; Kalesnikoff J; Lam V; Rosten P; Ware MD; Yew S; Humphries RK
Int J Biochem Cell Biol; 1999 Oct; 31(10):1007-10. PubMed ID: 10582334
[TBL] [Abstract][Full Text] [Related]
12. Small-molecule agonists of SHIP1 inhibit the phosphoinositide 3-kinase pathway in hematopoietic cells.
Ong CJ; Ming-Lum A; Nodwell M; Ghanipour A; Yang L; Williams DE; Kim J; Demirjian L; Qasimi P; Ruschmann J; Cao LP; Ma K; Chung SW; Duronio V; Andersen RJ; Krystal G; Mui AL
Blood; 2007 Sep; 110(6):1942-9. PubMed ID: 17502453
[TBL] [Abstract][Full Text] [Related]
13. Lipid phosphatases in the immune system.
Krystal G
Semin Immunol; 2000 Aug; 12(4):397-403. PubMed ID: 10995586
[TBL] [Abstract][Full Text] [Related]
14. The termination of PI3K signalling by SHIP1 and SHIP2 inositol 5-phosphatases.
Backers K; Blero D; Paternotte N; Zhang J; Erneux C
Adv Enzyme Regul; 2003; 43():15-28. PubMed ID: 12791379
[No Abstract] [Full Text] [Related]
15. SHIP-2 and PTEN are expressed and active in vascular smooth muscle cell nuclei, but only SHIP-2 is associated with nuclear speckles.
Déléris P; Bacqueville D; Gayral S; Carrez L; Salles JP; Perret B; Breton-Douillon M
J Biol Chem; 2003 Oct; 278(40):38884-91. PubMed ID: 12847108
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of SH2-containing inositol phosphatase 2 results in negative regulation of insulin-induced metabolic actions in 3T3-L1 adipocytes via its 5'-phosphatase catalytic activity.
Wada T; Sasaoka T; Funaki M; Hori H; Murakami S; Ishiki M; Haruta T; Asano T; Ogawa W; Ishihara H; Kobayashi M
Mol Cell Biol; 2001 Mar; 21(5):1633-46. PubMed ID: 11238900
[TBL] [Abstract][Full Text] [Related]
17. The role of SHIP1 in macrophage programming and activation.
Rauh MJ; Sly LM; Kalesnikoff J; Hughes MR; Cao LP; Lam V; Krystal G
Biochem Soc Trans; 2004 Nov; 32(Pt 5):785-8. PubMed ID: 15494015
[TBL] [Abstract][Full Text] [Related]
18. LPS-induced upregulation of SHIP is essential for endotoxin tolerance.
Sly LM; Rauh MJ; Kalesnikoff J; Song CH; Krystal G
Immunity; 2004 Aug; 21(2):227-39. PubMed ID: 15308103
[TBL] [Abstract][Full Text] [Related]
19. Reversible Ser/Thr SHIP phosphorylation: a new paradigm in phosphoinositide signalling?: Targeting of SHIP1/2 phosphatases may be controlled by phosphorylation on Ser and Thr residues.
Edimo WE; Janssens V; Waelkens E; Erneux C
Bioessays; 2012 Aug; 34(8):634-42. PubMed ID: 22641604
[TBL] [Abstract][Full Text] [Related]
20. Enzymatic and non-enzymatic activities of SHIP-1 in signal transduction and cancer.
Condé C; Gloire G; Piette J
Biochem Pharmacol; 2011 Nov; 82(10):1320-34. PubMed ID: 21672530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
